| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-10 17:56:13 UTC |
|---|
| Updated at | 2022-09-10 17:56:13 UTC |
|---|
| NP-MRD ID | NP0303523 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (1s,3r,5s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate |
|---|
| Description | Anisodamine belongs to the class of organic compounds known as tropane alkaloids. These are organic compounds containing the nitrogenous bicyclic alkaloid parent N-Methyl-8-azabicyclo[3.2.1]Octane. (1s,3r,5s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate is found in Anisodus tanguticus. (1s,3r,5s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate was first documented in 2020 (PMID: 33633726). Based on a literature review a significant number of articles have been published on anisodamine (PMID: 36087820) (PMID: 34967033) (PMID: 35892780) (PMID: 35915796) (PMID: 35636257) (PMID: 35601065). |
|---|
| Structure | CN1[C@H]2CC(O)[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1 InChI=1S/C17H23NO4/c1-18-12-7-13(9-15(18)16(20)8-12)22-17(21)14(10-19)11-5-3-2-4-6-11/h2-6,12-16,19-20H,7-10H2,1H3/t12-,13-,14?,15+,16?/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Anisodamine hydrobromide | MeSH | | Racanisodamine | MeSH | | 6-Hydroxyhyoscyamine | MeSH |
|
|---|
| Chemical Formula | C17H23NO4 |
|---|
| Average Mass | 305.3740 Da |
|---|
| Monoisotopic Mass | 305.16271 Da |
|---|
| IUPAC Name | (1S,3R,5S)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate |
|---|
| Traditional Name | (1S,3R,5S)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CN1[C@H]2CC(O)[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C17H23NO4/c1-18-12-7-13(9-15(18)16(20)8-12)22-17(21)14(10-19)11-5-3-2-4-6-11/h2-6,12-16,19-20H,7-10H2,1H3/t12-,13-,14?,15+,16?/m1/s1 |
|---|
| InChI Key | WTQYWNWRJNXDEG-AQIKHJSRSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as tropane alkaloids. These are organic compounds containing the nitrogenous bicyclic alkaloid parent N-Methyl-8-azabicyclo[3.2.1]Octane. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Alkaloids and derivatives |
|---|
| Class | Tropane alkaloids |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Tropane alkaloids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Tropane alkaloid
- Beta-hydroxy acid
- Benzenoid
- N-alkylpyrrolidine
- Piperidine
- Hydroxy acid
- Monocyclic benzene moiety
- Pyrrolidine
- Cyclic alcohol
- Tertiary aliphatic amine
- Tertiary amine
- Secondary alcohol
- Carboxylic acid ester
- Amino acid or derivatives
- 1,2-aminoalcohol
- Azacycle
- Organoheterocyclic compound
- Monocarboxylic acid or derivatives
- Carboxylic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Primary alcohol
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Amine
- Alcohol
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Qiao M, Zhang L, Xu C, Huo X, Chang J, Su J: Chitosan and anisodamine enhance the immersion immune efficacy of inactivated Elizabethkingia miricola vaccine in black spotted frogs. Fish Shellfish Immunol. 2022 Nov;130:93-102. doi: 10.1016/j.fsi.2022.08.072. Epub 2022 Sep 8. [PubMed:36087820 ]
- Wang B, Chen T, Wang A, Fang J, Wang J, Yao W, Wu Y: Anisodamine affects the pigmentation, mineral density, craniofacial area, and eye development in zebrafish embryos. J Appl Toxicol. 2022 Jun;42(6):1067-1077. doi: 10.1002/jat.4278. Epub 2021 Dec 29. [PubMed:34967033 ]
- Vera-Baquero FL, Morante-Zarcero S, Sierra I: Evaluation of Thermal Degradation of Tropane and Opium Alkaloids in Gluten-Free Corn Breadsticks Samples Contaminated with Stramonium Seeds and Baked with Poppy Seeds under Different Conditions. Foods. 2022 Jul 23;11(15):2196. doi: 10.3390/foods11152196. [PubMed:35892780 ]
- Wang J, Zhu Q, Zhang S, Wen L, Wang L: Observation of Clinical Efficacy of Anisodamine and Chlorpromazine in the Treatment of Intractable Hiccup after Stroke. Biomed Res Int. 2022 Jul 11;2022:6563193. doi: 10.1155/2022/6563193. eCollection 2022. [PubMed:35915796 ]
- Wei W, Kong N, Liu MZ, Han T, Xu JF, Liu C: Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease. Biochem Biophys Res Commun. 2022 Aug 6;616:8-13. doi: 10.1016/j.bbrc.2022.05.024. Epub 2022 May 13. [PubMed:35636257 ]
- Dong GJ, Yang J, Zhao X, Guo SB: Anisodamine hydrobromide ameliorates cardiac damage after resuscitation. Exp Ther Med. 2022 Jun;23(6):422. doi: 10.3892/etm.2022.11349. Epub 2022 May 3. [PubMed:35601065 ]
- Wang C, Zhu D, Zhang J, Du Y: Homochiral iron-based gamma-cyclodextrin metal-organic framework for stereoisomer separation in the open tubular capillary electrochromatography. J Pharm Biomed Anal. 2022 Jun 5;215:114777. doi: 10.1016/j.jpba.2022.114777. Epub 2022 Apr 19. [PubMed:35462287 ]
- Zhang Y, Song D, Peng Z, Wang R, Li K, Ren H, Sun X, Du N, Tang SC: Anisodamine Enhances Macrophage M2 Polarization through Suppressing G9a-Mediated Interferon Regulatory Factor 4 Silencing to Alleviate Lipopolysaccharide-Induced Acute Lung Injury. J Pharmacol Exp Ther. 2022 Jun;381(3):247-256. doi: 10.1124/jpet.121.001019. Epub 2022 Apr 5. [PubMed:35383125 ]
- Honore PM, Redant S, Preseau T, Cismas BV, Kaefer K, Barreto Gutierrez L, Anane S, Attou R, Gallerani A, De Bels D: Anisodamine microcirulatory effects in septic shock: be aware of cardiac side effects. Crit Care. 2021 Dec 16;25(1):433. doi: 10.1186/s13054-021-03854-5. [PubMed:34915896 ]
- Lyu SC, Wang J, Xu WL, Wang HX, Pan F, Jiang T, He Q, Lang R: Therapeutic Effect of Combining Anisodamine With Neostigmine on Local Scar Formation Following Roux-en-Y Choledochojejunostomy in a Novel Rat Model. Front Pharmacol. 2021 Sep 29;12:700050. doi: 10.3389/fphar.2021.700050. eCollection 2021. [PubMed:34658849 ]
- Lin X, Chen H, Lin YN: The clinical efficacy and safety of atropine combined with omeprazole in the treatment of patients with acute gastritis: a systematic review and meta-analysis. Ann Palliat Med. 2021 Sep;10(9):9535-9543. doi: 10.21037/apm-21-1868. [PubMed:34628879 ]
- Yu Y, Zhu C, Hong Y, Chen L, Huang Z, Zhou J, Tian X, Liu D, Ren B, Zhang C, Hu C, Wang X, Yin R, Gao Y, Zhang Z: Effectiveness of anisodamine for the treatment of critically ill patients with septic shock: a multicentre randomized controlled trial. Crit Care. 2021 Sep 27;25(1):349. doi: 10.1186/s13054-021-03774-4. [PubMed:34579741 ]
- Cheng X, Liu Y, Wang Z, Qu L, Ning Z: Active Yeast but Not Henhouse Environment Affects Dropping Moisture Levels in Egg-Laying Hens. Animals (Basel). 2021 Jul 23;11(8):2179. doi: 10.3390/ani11082179. [PubMed:34438640 ]
- Zhao X, Zhao B, Zhao Y, Zhang Y, Qian M: Protective effect of anisodamine on bleomycin-induced acute lung injury in immature rats via modulating oxidative stress, inflammation, and cell apoptosis by inhibiting the JAK2/STAT3 pathway. Ann Transl Med. 2021 May;9(10):859. doi: 10.21037/atm-21-1750. [PubMed:34164493 ]
- Authors unspecified: Withdrawn: Anisodamine (654-2) inhibits inflammation to alleviate influenza A virus-induced acute lung injury. J Med Virol. 2021 Dec;93(12):6850. doi: 10.1002/jmv.27043. [PubMed:34076913 ]
- Liu Z, Wang W, Luo J, Zhang Y, Zhang Y, Gan Z, Shen X, Zhang Y, Meng X: Anti-Apoptotic Role of Sanhuang Xiexin Decoction and Anisodamine in Endotoxemia. Front Pharmacol. 2021 Apr 21;12:531325. doi: 10.3389/fphar.2021.531325. eCollection 2021. [PubMed:33967742 ]
- Zhang S, Xu X, Huang Y, Sun S, Jin C, Ji H, Sun D, Xia A: Anisodamine ameliorates ischemia/reperfusion-induced renal injury in rats through activation of the extracellular signal-regulated kinase (ERK) pathway and anti-apoptotic effect. Pharmazie. 2021 May 1;76(5):220-224. doi: 10.1691/ph.2021.1302. [PubMed:33964996 ]
- Bai S, Wang X, Wu H, Chen T, Li X, Zhang L, Li X, Er L, Du R: Cardioprotective effect of anisodamine against ischemia/reperfusion injury through the mitochondrial ATP-sensitive potassium channel. Eur J Pharmacol. 2021 Jun 15;901:174095. doi: 10.1016/j.ejphar.2021.174095. Epub 2021 Apr 20. [PubMed:33862063 ]
- Qin Z, Xiang K, Su DF, Sun Y, Liu X: Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19. Front Immunol. 2021 Feb 8;11:595342. doi: 10.3389/fimmu.2020.595342. eCollection 2020. [PubMed:33633726 ]
- LOTUS database [Link]
|
|---|